PMPeter M. Mourani

Peter M. Mourani

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Peter M. Mourani has a total of 7 co-authors. Here are the top co-authors by number of shared publications:

  • D. Dunbar Ivy

    †Division of Cardiology, The Pediatric Heart-Lung Center, Department of Pediatrics, The Children’s Hospital and University of Colorado at Denver and Health Sciences Center, Denver, Colorado

    3 shared publications
  • Steven H. Abman

    ‡Division of Pulmonary Medicine, The Pediatric Heart-Lung Center, Department of Pediatrics, The Children’s Hospital and University of Colorado at Denver and Health Sciences Center, Denver, Colorado

    3 shared publications
  • Adam A. Rosenberg

    §Division of Neonatology, The Pediatric Heart-Lung Center, Department of Pediatrics, The Children’s Hospital and University of Colorado at Denver and Health Sciences Center, Denver, Colorado

    1 shared publication
  • Adel Younoszai

    Cardiology

    1 shared publication
  • Dexiang Gao

    Divisions of Critical Care, Cardiology, and Pulmonary Medicine, The Pediatric Heart-Lung Center, Department of Pediatrics, The Children's Hospital and University of Colorado Health Sciences Center, Denver, Colorado

    1 shared publication
  • Marci K. Sontag

    Department of Preventative Medicine and Biometrics, Children's Hospital and University of Colorado Denver School of Medicine, Denver, Colorado

    1 shared publication

Latest Publications

  • Clinical Utility of Echocardiography for the Diagnosis and Management of Pulmonary Vascular Disease in Young Children With Chronic Lung Disease

    by Peter M. Mourani, Marci K. Sontag, Adel Younoszai, D. Dunbar Ivy, Steven H. Abman

    OBJECTIVE. The goal was to determine the clinical utility of Doppler echocardiography in predicting the presence and severity of pulmonary hypertension in patients with chronic lung disease who subsequently underwent cardiac catheterization. METHODS. A retrospective review of data for all patients <2 years of age with a diagnosis of bronchopulmonary dysplasia, congenital diaphragmatic hernia, or lung hypoplasia who underwent echocardiography and subsequently underwent cardiac catheterization for evaluation of pulmonary hypertension was performed. The accuracy of echocardiography in diagnosing pulmonary hypertension, on the basis of estimated systolic pulmonary artery pressure, was compared with the detection of pulmonary hypertension with the standard method of cardiac catheterization. RESULTS. Thirty-one linked measurements for 25 children were analyzed. Systolic pulmonary artery pressure could be estimated in 61% of studies, but there was poor correlation between echocardiography and cardiac catheterization measures of systolic pulmonary artery pressure in these infants. Compared with cardiac catheterization measurements, echocardiographic estimates of systolic pulmonary artery pressure diagnosed correctly the presence or absence of pulmonary hypertension in 79% of the studies in which systolic pulmonary artery pressure was estimated but determined the severity of pulmonary hypertension (severe pulmonary hypertension was defined as pulmonary/systemic pressure ratio of ≥0.67) correctly in only 47% of those studies. Seven (58%) of 12 children without estimated systolic pulmonary artery pressure demonstrated pulmonary hypertension during subsequent cardiac catheterization. In the absence of estimated systolic pulmonary artery pressure, qualitative echocardiographic findings, either alone or in combination, had worse predictive value for the diagnosis of pulmonary hypertension. CONCLUSION. As used in clinical practice, echocardiography often identifies pulmonary hypertension in young children with chronic lung disease; however, estimates of systolic pulmonary artery pressure were not obtained consistently and were not reliable for determining the severity of pulmonary hypertension.


  • Left Ventricular Diastolic Dysfunction in Bronchopulmonary Dysplasia

    by Peter M. Mourani, D. Dunbar Ivy, Adam A. Rosenberg, Thomas E. Fagan, Steven H. Abman


  • Pulmonary Vascular Effects of Inhaled Nitric Oxide and Oxygen Tension in Bronchopulmonary Dysplasia

    by Peter M. Mourani, D. Dunbar Ivy, Dexiang Gao, Steven H. Abman

    Pulmonary hypertension contributes significantly to morbidity and mortality in bronchopulmonary dysplasia (BPD), but little is known about the relative contribution of arterial tone, structural remodeling, and vessel density to pulmonary hypertension, especially in older patients. To determine the role of high pulmonary vascular tone in pulmonary hypertension, we studied the acute effects of oxygen tension, inhaled nitric oxide (iNO), and calcium channel blockers (CCB) in 10 patients with BPD who underwent cardiac catheterization for evaluation of pulmonary hypertension. During normoxic conditions, mean pulmonary arterial pressure (PAP) and pulmonary to systemic vascular resistance ratio (PVR/SVR) were 34 ± 3 mm Hg and 0.42 ± 0.07, respectively. In response to hypoxia, PAP and PVR/SVR increased by 50 ± 8% and 82 ± 14%, respectively (p < 0.01). Hyperoxia decreased PVR/SVR by 28 ± 9% (p = 0.05). The addition of iNO treatment (20–40 ppm) to hyperoxia decreased PAP and PVR/SVR by 29 ± 5% (p < 0.01) and 45 ± 6% (p < 0.05) from baseline values, respectively, achieving near normal values. CCB did not alter PAP or PVR/SVR from baseline values. We conclude that hyperoxia plus iNO causes marked pulmonary vasodilatation in older patients with BPD, suggesting that heightened pulmonary vascular tone contributes to pulmonary vascular disease in BPD.